Benitec Limited DNA-Directed RNAi Technology Suppresses BIII-Tubulin In A Human Lung Cancer Model

Sydney, June 16, 2010 (ABN Newswire) - Benitec Limited (ASX:BLT) (PINK:BNIKF) are pleased to announce the publication of a paper in the prestigious scientific journal Cancer Research by Associate Professor Maria Kavallaris from Children's Cancer Institute Australia for Medical Research (CCIA) and the University of New South Wales (UNSW), relating to the association between beta tubulin and chemotherapy resistance in cancers.

Back to news